Literature DB >> 29486961

The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function.

Christian Sina1, Claudia Kemper2, Stefanie Derer3.   

Abstract

The complement system is part of innate sensor and effector systems such as the Toll-like receptors (TLRs). It recognizes and quickly systemically and/or locally respond to microbial-associated molecular patterns (MAMPs) with a tailored defense reaction. MAMP recognition by intestinal epithelial cells (IECs) and appropriate immune responses are of major importance for the maintenance of intestinal barrier function. Enterocytes highly express various complement components that are suggested to be pivotal for proper IEC function. Appropriate activation of the intestinal complement system seems to play an important role in the resolution of chronic intestinal inflammation, while over-activation and/or dysregulation may worsen intestinal inflammation. Mice deficient for single complement components suffer from enhanced intestinal inflammation mimicking the phenotype of patients with chronic inflammatory bowel disease (IBD) such as Crohn's disease (CD) or ulcerative colitis (UC). However, the mechanisms leading to complement expression in IECs seem to differ markedly between UC and CD patients. Hence, how IECs, intestinal bacteria and epithelial cell expressed complement components interact in the course of IBD still remains to be mostly elucidated to define potential unique patterns contributing to the distinct subtypes of intestinal inflammation observed in CD and UC.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic inflammatory bowel disease; Complement system; Crohn’s disease; Intestinal epithelial cells; Ulcerative colitis

Mesh:

Substances:

Year:  2018        PMID: 29486961     DOI: 10.1016/j.smim.2018.02.008

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  33 in total

1.  Back to the future - non-canonical functions of complement.

Authors:  Claudia Kemper; Jörg Köhl
Journal:  Semin Immunol       Date:  2018-06       Impact factor: 11.130

2.  Neonatal thrombotic microangiopathy secondary to factor I variant with Hirschsprung disease.

Authors:  Adi Nitzan-Luques; Mordechai Slae; Diaa Zugayar; Bradley P Dixon; Karen Meir; Oded Volovelsky
Journal:  J Nephrol       Date:  2020-06-08       Impact factor: 3.902

3.  Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.

Authors:  Y H Sun; J Li; H J Shu; Z L Li; J M Qian
Journal:  Clin Transl Oncol       Date:  2019-04-06       Impact factor: 3.405

4.  Lizhong Decoction Ameliorates Ulcerative Colitis in Mice via Regulation of Plasma and Urine Metabolic Profiling.

Authors:  Ling Wang; Jin-Hua Tao; Yi-Fan Chen; Yu-Meng Shen; Shu Jiang
Journal:  Chin J Integr Med       Date:  2021-09-29       Impact factor: 2.626

Review 5.  New directions in necrotizing enterocolitis with early-stage investigators.

Authors:  Troy A Markel; Colin A Martin; Hala Chaaban; Jennifer Canvasser; Heather Tanner; Heather Denchik; Misty Good
Journal:  Pediatr Res       Date:  2020-08       Impact factor: 3.756

6.  Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Ulcerative Colitis.

Authors:  Zi-An Chen; Yu-Feng Sun; Quan-Xu Wang; Hui-Hui Ma; Zhi-Zhao Ma; Chuan-Jie Yang
Journal:  Front Genet       Date:  2021-07-09       Impact factor: 4.599

7.  Pinocembrin alleviates ulcerative colitis in mice via regulating gut microbiota, suppressing TLR4/MD2/NF-κB pathway and promoting intestinal barrier.

Authors:  Bei Yue; Junyu Ren; Zhilun Yu; Xiaoping Luo; Yijing Ren; Jing Zhang; Sridhar Mani; Zhengtao Wang; Wei Dou
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

8.  Congruence of Transcription Programs in Adult Stem Cell-Derived Jejunum Organoids and Original Tissue During Long-Term Culture.

Authors:  Bart van der Hee; Ole Madsen; Jacques Vervoort; Hauke Smidt; Jerry M Wells
Journal:  Front Cell Dev Biol       Date:  2020-07-02

9.  Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History Registry.

Authors:  Alyce Anderson; Cynthia Cherfane; Benjamin Click; Claudia Ramos-Rivers; Ioannis E Koutroubakis; Jana G Hashash; Dmitriy Babichenko; Gong Tang; Michael Dunn; Arthur Barrie; Siobhan Proksell; Jeffrey Dueker; Elyse Johnston; Marc Schwartz; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2022-01-05       Impact factor: 5.325

Review 10.  Preventing Colorectal Cancer through Prebiotics.

Authors:  Manijeh Mahdavi; Isabelle Laforest-Lapointe; Eric Massé
Journal:  Microorganisms       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.